Booster research - good news on 2 fronts

[dreamshark]

As I have commented before, a policy of endless boosters of the original vaccines at constantly decreasing intervals is not a viable long term strategy for combatting the evolving coronavirus. It might be worth pursuing as a short-term crisis response targeted to vulnerable people, but more data is desperately needed. And of course what we really need is those next-gen vaccines that are reportedly under development now. Here's some good news on both fronts.

I just found this article about a study that NIAID is sponsoring at the University of Rochester that will both evaluate the efficacy of booster #2 and (more excitingly) fold in trials of "new investigational vaccines that target the Beta, Delta, and Omicron variants."